Search research articles
Contact Us
Filters
Showing results (1-10 of 69) with videos related to
Page
of 7
Sort By:
British Journal of Cancer
|
September 29, 2020
Bromodomain inhibitors a decade later: a promise unfulfilled?
Monica M Mita, Alain C Mita
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 20, 2006
Design, conduct, and interpretation of organ impairment studies in oncology patients
Chris H Takimoto, Alain C Mita
Targeted Oncology
|
December 17, 2024
FGFR-Altered Urothelial Carcinoma: Resistance Mechanisms and Therapeutic Strategies
David J Benjamin, Alain C Mita
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 24, 2012
Cabazitaxel: more than a new taxane for metastatic castrate-resistant prostate cancer?
Alain C Mita, Robert Figlin, Monica M Mita
Clinical Colorectal Cancer
|
August 3, 2004
Development of rationally designed, target-based agents for the treatment of advanced colorectal cancer
Alain C Mita, Monica M Mita, Eric K Rowinsky
World Journal of Methodology
|
March 29, 2016
Clinical development of reovirus for cancer therapy: An oncolytic virus with immune-mediated antitumor activity
Jun Gong, Esha Sachdev, Alain C Mita, et al.
Current Drug Targets
|
July 23, 2011
The hedgehog knows many tricks
Glen J Weiss, Alain C Mita, Daniel D Von Hoff
Expert Opinion on Investigational Drugs
|
January 16, 2013
Vascular-disrupting agents in oncology
Monica M Mita, Liza Sargsyan, Alain C Mita, et al.
Targeted Oncology
|
May 5, 2011
Clinical activity of mammalian target of rapamycin inhibitors in solid tumors
Yesid Alvarado, Monica M Mita, Sushma Vemulapalli, et al.
Current Drug Targets
|
July 23, 2011
Heat shock proteins: a potential anticancer target
Kamalesh K Sankhala, Monica M Mita, Alain C Mita, et al.
Page
of 7
Search research articles
Search
Showing results (1-10 of 69) with videos related to
Sort By:
Page
of 7
British Journal of Cancer
|
September 29, 2020
Bromodomain inhibitors a decade later: a promise unfulfilled?
Monica M Mita, Alain C Mita
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 20, 2006
Design, conduct, and interpretation of organ impairment studies in oncology patients
Chris H Takimoto, Alain C Mita
Targeted Oncology
|
December 17, 2024
FGFR-Altered Urothelial Carcinoma: Resistance Mechanisms and Therapeutic Strategies
David J Benjamin, Alain C Mita
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 24, 2012
Cabazitaxel: more than a new taxane for metastatic castrate-resistant prostate cancer?
Alain C Mita, Robert Figlin, Monica M Mita
Clinical Colorectal Cancer
|
August 3, 2004
Development of rationally designed, target-based agents for the treatment of advanced colorectal cancer
Alain C Mita, Monica M Mita, Eric K Rowinsky
World Journal of Methodology
|
March 29, 2016
Clinical development of reovirus for cancer therapy: An oncolytic virus with immune-mediated antitumor activity
Jun Gong, Esha Sachdev, Alain C Mita, et al.
Current Drug Targets
|
July 23, 2011
The hedgehog knows many tricks
Glen J Weiss, Alain C Mita, Daniel D Von Hoff
Expert Opinion on Investigational Drugs
|
January 16, 2013
Vascular-disrupting agents in oncology
Monica M Mita, Liza Sargsyan, Alain C Mita, et al.
Targeted Oncology
|
May 5, 2011
Clinical activity of mammalian target of rapamycin inhibitors in solid tumors
Yesid Alvarado, Monica M Mita, Sushma Vemulapalli, et al.
Current Drug Targets
|
July 23, 2011
Heat shock proteins: a potential anticancer target
Kamalesh K Sankhala, Monica M Mita, Alain C Mita, et al.
Page
of 7